EUCTR2007-000780-21-GB进行中（未招募）不适用
A randomised, single-masked, Phase IV pilot study of the efficacy and safety of adjunctive intravitreal Avastin® (bevacizumab) in the prevention of early postoperative vitreous haemorrhage following diabetic vitrectomy - Intravitreal Avastin® in diabetic vitrectomy
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Non-clearing or recurrent vitreous haemorrhage due to proliferative diabetic retinopathy – indicated for PPV.
- •Visual acuity better than perception of light.
- •Patient fit for and agreed to have pars plana vitrectomy
- •Age > 20 years old
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Previous vitrectomy
- •Ocular and systemic contra-indication for vitrectomy
- •Unfit for local or general anaesthesia
- •Inability to obtain visual acuity, fundus imaging or fluorescein angiogram.
- •Reduced potential visual acuity due to corneal or optic nerve disease, or amblyopia
- •Previous intravitreal Avastin® injection in either eye
- •Inability to give informed consent
- •Inability to comply with follow-up visit and investigation
- •Women of child-bearing age or currently breast feeding
- •Recent (< 1 month) acute myocardial infarct, transient ischaemic attack or stroke.
研究者
相似试验
已完成
不适用
A randomised, single-masked, phase IV pilot study of the efficacy and safety of adjunctive intravitreal Avastin® (bevacizumab) in the prevention of early postoperative vitreous haemorrhage following diabetic vitrectomyDiabetic retinopathyISRCTN79120387Moorfields Eye Hospital NHS Foundation Trust (UK)30
进行中（未招募）
不适用
Prospective, randomized, single masked pilot study on the variation of choroidal blood flow analyzed through the HRA dynamic angiography in patients treated with intravitreal injection of Selective anti-VEGF (Macugen) or Pan anti-VEGF (Avastin). - NDEUCTR2008-001600-23-ITAZIENDA OSPEDALIERA L. SACCO (A.O. DI RILIEVO NAZIONALE)
尚未招募
不适用
Randomised comparison of the Ambu® Laryngeal Mask with the Laryngeal Mask Airway UniqueTM during anaesthesia in spontaneously breathing adult patientsAirway maintenance during anaesthesiaAnaesthesiology - Other anaesthesiologyRespiratory -ACTRN12606000429550Royal Melbourne Hospital - Department of Anaesthesia and Pain Management100
尚未招募
4 期
A clinical study to evaluate the efficacy and safety of Nisha-Amalki capsules in preventing progression to Diabetes in patients with Pre-DiabetesCTRI/2018/08/015503PHARMANZA HERBAL PVT LTD
进行中（未招募）
1 期
A study to evaluate immunogenicity and safety of GlaxoSmithKline (GSK)'s Infanrix hexa vaccine (DTPa HBV IPV/Hib) versus MCM Vaccine BV's Vaxelis vaccine (DTaP5 HBV IPV Hib) in healthy infants and toddlersEUCTR2019-002988-10-ITGLAXOSMITHKLINE BIOLOGICALS500